Equity Incentive Plans and Employee Stock Purchase Plan (Tables)

3 Months Ended

Apr. 30, 2023

Share-Based Payment Arrangement [Abstract]

The following table summarizes stock option activity for the three months ended April 30, 2023 (in thousands, except share and per share data and years):


	Shares	Weighted-Average Exercise Price Per Share		Weighted- Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value
Balance - January 31, 2023	1,789,813	$	7.60	3.3	$	313,980
Stock options exercised	(213,713)	6.89
Stock options forfeited and expired	—	—
Balance - April 30, 2023	1,576,100	$	7.70	3.1	$	366,065
Vested and exercisable - January 31, 2023	1,789,813	$	7.60	3.3	$	313,980
Vested and exercisable - April 30, 2023	1,576,100	$	7.70	3.1	$	366,065

Schedule of restricted stock unit activity

The following table summarizes RSU activity for the three months ended April 30, 2023:


	Shares	Weighted-Average Grant Date Fair Value per RSU
Unvested - January 31, 2023	3,480,206	$	288.58
RSUs granted	1,564,517	217.42
RSUs vested	(388,017)	250.23
RSUs forfeited and canceled	(168,192)	306.20
Unvested - April 30, 2023	4,488,514	$	276.15

Schedule of stock-based compensation expense recognized in consolidated statements of operations

Total stock-based compensation expense recognized in the Company’s unaudited condensed consolidated statements of operations is as follows (in thousands):


	Three Months Ended April 30,
		2023		2022
Cost of revenue—subscription		$	5,514	$	4,467
Cost of revenue—services		2,948		2,212
Sales and marketing		37,606		30,534
Research and development		44,066		35,483
General and administrative		13,821		10,870
Total stock-based compensation expense		$	103,955	$	83,566